Table 3.

Clinicopathological parameters in relation to p34^cdc2 expression in tumour nuclei (p34^cdc2TN)

	p34cdc2TN expression				p Value
1+	2+	3+	4+
Age (years)
<50	6	17	12	5
⩾50	8	22	22	2	0.702
Menopausal
Pre	4	16	11	4
Post	9	22	23	3	0.663
T size
T1	8	16	19	1
T2	6	23	15	6	0.47
Grade
1	5	12	4	–
2	6	19	13	–
3	3	8	17	7	<0.001
p34cdc2TC
<10%	8	17	4	–
⩾10%	5	21	29	7	<0.001
p34cdc2bn
<10%	11	26	21	4
⩾10%	1	3	7	1	0.154
p53
<10%	13	30	23	3
⩾10%	1	6	10	4	0.005
p21WAF1
<6%	8	20	14	6
⩾6%	6	19	20	1	0.875
ER
Negative	6	13	13	5
Positive	8	24	20	2	0.364
PR
Negative	6	18	17	5
Positive	8	21	16	2	0.244
Relapse
No	13	32	31	6
Yes	1	7	3	1	0.900
Death
No	13	36	31	6
Yes	1	3	3	1	0.624

ER, oestrogen receptor; p34^cdc2bn, p34^cdc2 expression in benign breast tissue; p34^cdc2TC, p34^cdc2 expression in tumour cytoplasm; PR, progesterone receptor.